Compare Eli Lilly And Co (LLY) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Quantumscape Corp — how do they compare? Eli Lilly And Co trades at $1,215.51 (market cap $1.10T), while Quantumscape Corp trades at $6.38 (market cap $3.81B). The key difference: Eli Lilly And Co is far larger — about 288.7× Quantumscape Corp's market cap, and Eli Lilly And Co pays a 0.56% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.
| LLY | QS | |
|---|---|---|
Market Cap | $1.10T | $3.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $18.44 |
52-Week Low | $639.43 | $4.89 |
Enterprise Value | $1.14T | $3.02B |
Dividend Yield | 0.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,185.71, down 0.59% on the day, with a bullish technical signal from moving averages and strong fundamental momentum. The company reported Q2 2026 revenue growth of 48% to $23 billion, beating estimates, driven by demand for Mounjaro and Zepbound. Valuation ratios like P/E of 39.8 and P/S of 13.34 reflect high growth expectations, while profitability remains robust with a net income margin of 33.53%.
Outlook is positive due to pipeline advancements like retatrutide and raised 2026 guidance, but risks include competitive pressures and regulatory scrutiny. Analysts are bullish with a consensus price target of $1,380, citing sustained double-digit growth and market leadership in weight-loss drugs as key drivers for upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
